Click sobre imagen para ampliar
The fully diversified model is one in which a company expands from its core business into the provision of related products and services, such as diagnostics and devices, generics, nutraceuticals and health management. Johnson & Johnson is Pharma’s leading exponent of this approach. It is now the world’s largest consumer health company, following the US$16.6 billion acquisition of Pfizer’s over-the-counter business in December 2006.27 It is also the third-largest biologics and sixthlargest pharmaceutical company, has an extensive medical devices and diagnostics operation,28 and recently started building a wellness and prevention platform, with the purchase of HealthMedia, a web-based “health coach”
Ver anteriores
jueves, 24 de septiembre de 2009
PRICE WATERHOUSE: Pharma 2020: Challenging business models Which path will you take? (II) Modelo Diversificado
Etiquetas:
Agrupaciones,
Genéricos,
Investigación,
J_J,
Mercados,
OTC,
Pfizer
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario